Ontario is committed to protecting species at risk and their habitats. That’s why we are accepting applications for the 2019-2020 Species at Risk Stewardship Program which supports communities, organizations and other partners to implement on-the-ground activities that benefit species and their habitats.

Applications must be received electronically by 3:00pm (EST) on Thursday, May 9, 2019.

The 2019/20 Species at Risk Stewardship Program guidelines and application form can be found by following the links on the Ontario Species at Risk website: https://www.ontario.ca/environment-and-energy/species-risk-stewardship-fund. The guidelines and application form are also attached to this email. Applicants are asked to carefully read the guidelines before completing and submitting an application. 

Priorities have been identified for the 2019/20 funding year and are outlined within the guidelines. Please review the priorities in detail. Applications that do not address a 2019/20 priority will only be considered for funding after priority applications.

Completed applications may be submitted via e-mail to sar.stewardship@ontario.ca. At this time, applications are being accepted for both the Species at Risk Stewardship Fund (SARSF) and the Species at Risk Research Fund for Ontario (SARRFO) for the 2019-20 funding year only.

Please note, if you are a current SARSF or SARRFO recipient and have a multi-year agreement with the province, funding has been confirmed for the 2019/2020 funding year meaning payments will be made subject to the terms and conditions of your agreement.

Applicants are encouraged to contact species experts early in the planning process for advice on developing their project proposals. MECP staff can also assist applicants in determining whether an authorization under theEndangered Species Act may be required via e-mail at sarontario@ontario.ca.

For more information, please contact Allison.Marinich@ontario.ca or 705-755-5649.

Through its Postdoctoral Fellowship Program, Canadian Blood Services offers salary support for young investigators. Postdoctoral fellows undertaking full-time research training in a Canadian research laboratory affiliated with Canadian Blood Services are invited to apply. The fellowship provides salary support plus benefits, and a one-time research allowance of $20,000. Fellows may be supported for a maximum of three years.

Current competition:

Application deadline: July 15, 2019

Canadian Blood Services is pleased to announce its 2019 Blood Efficiency Accelerator Award Program Competition. The objective of the Program is to improve the efficient and appropriate utilization of blood products, while maintaining the safety of the blood system.

Examples of projects funded through this program in previous competitions include:

• A program to minimize preventable and inappropriate blood product transfusions in liver surgery
• Feasibility in Canada for a non-invasive prenatal testing using single-exon fetal RHD determination
• Assessment of the quality of granulocyte concentrates to optimize their use in transfusion therapy
• Optimizing rejuvenation to improve the product quality of pathogen-inactivation and gamma-irradiated red cell concentrates.

Read our blog post to learn more about the funding opportunity.

For detailed information about the Blood Efficiency Accelerator Award Program competition, please refer to www.blood.ca. The deadline to submit completed application packages is July 15 2019.

The Genomic Applications Partnership Program (GAPP) funds downstream research and development (R&D) projects that address real world opportunities and challenges defined by “Receptor” organizations such as industry, government, or not-for-profit entities. These organizations should be committed to commercializing or implementing the outcomes of the project.

Projects are led by the Receptor organization (Canadian or international) but are active collaborations with a Canadian academic researcher. These projects are co-funded by Receptors and other stakeholders and must have the potential to generate significant social and/or economic benefits for Canada.

The GAPP aims to:

• Accelerate the application of Canadian genomics-derived solutions from academia to real-world opportunities and challenges defined by industry, not-for-profit and public-sector Receptors.
• Channel Canada’s genomics capacity into sustainable innovations that benefit Canadians.
• Enhance the value of Canadian genomics technologies by de-risking and incentivizing follow-on investment from industry and other partners.
• Foster mutually beneficial collaboration and knowledge exchange between Canadian academia and technology receptors.

The FY19 Defense Appropriation provides $30 million (M) to the Department of Defense Spinal Cord Injury Research Program (SCIRP) to support innovative, high-impact spinal cord injury research. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate, manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC).

FY19 SCIRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.

For FY19, SCIRP encourages applications that address the critical needs of SCI research and patient care in one or more of the following FY19 Focus Areas:

• Neuroprotection
• Biomarkers
• Bladder dysfunction,  bowel dysfunction and neuropathic pain
• Psychosocial issues relevant to SCI in  individuals with SCI or their caregivers
• Rehabilitation and regeneration

https://cdmrp.army.mil/funding/scirp

Clinical Trial Award – Preproposal due May 29, 2019

Independent investigators at all academic levels (or equivalent)

• Fund Phase 0, I, or II clinical trials with the potential to have a major impact on treatment or management of spinal cord injury (SCI) and its consequences.
• Applications must include at least two SCI consumer advocates as members of the research team.
• Preliminary data relevant to the proposed trial required for all clinical trial applications.
• Pre-application required; application submission is by invitation only.
• The maximum allowable funding for the entire period of performance is of $3, 000,000 for direct costs.
• Indirect costs may be proposed in accordance with the institutions’ negotiated rate agreement.
• The maximum period of performance is 4 years

Investigator-Initiated Research Award – Preproposal due May 29, 2019

Independent investigators at all academic levels (or equivalent)

• Fund SCI-related research that has the potential to make an important contribution to SCI research and/or patient care, and/or quality of life.
• Preliminary data required.
• Clinical trials not allowed.
• Pre-application required; application submission by invitation only.
• The maximum allowable funding for the entire period of performance is $500,000 for direct costs.
• Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
• The maximum period of performance is 3 years.

Translational Research Award – Preproposal due May 29, 2019

Independent investigators at all academic levels (or equivalent)

• Fund studies that accelerate the movement of promising ideas in SCI research into clinical applications.
• Applications must include at least one SCI consumer advocate as a member of the research team.
• Preliminary data required
• The SCIRP TRA may include a pilot clinical trial where limited clinical testing of a novel intervention or device is necessary to inform the next step in the continuum of translational research.
• Pre-application required; application submission by invitation only.
• The maximum allowable funding for the entire period of performance is $1,250,000 for direct costs.
• Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
• The maximum period of performance is 3 years

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism is also on Grants.gov.  A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the SCIRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk

301-682-5507 
help@eBrap.org

Marie Sklodowska-Curie Actions (MSCA) Program
INDIVIDUAL FELLOWSHIPS - EUROPE

*** WEBINAR: How to Write a Successful MSC-IF Proposal ***
23 April 2019 8:00am-10:am EST (2:00 – 4:00 CEST)
(REGISTRATION REQUIRED)

Eligibility: 

PhD or at least 4 years of full-time research experience
All disciplines
From anywhere in the world

Deadline: 11 September 2019

Individual Fellowships provide opportunities to experienced researchers of any nationality to acquire and transfer new knowledge and to work on research and innovation in Europe (EU Member States and Horizon 2020 Associated Countries) and beyond. The goal of the MSC-IF program is to enhance the creative and innovative potential of experienced researchers, wishing to diversify their individual competence in terms of skill acquisition through advanced training, international and intersectoral mobility.

Fellowships last from 1-2 years, and can include a secondment period of 3 – 6 months with another organisation in Europe.

The grant provides an allowance to cover living, travel and family costs. In addition, the EU contributes to the training, networking and research costs of the fellow, as well as to the management and indirect costs of the project.

The grant is awarded to the host organisation, usually a university, research centre or a company in Europe.

How to apply:
You submit a research proposal, including your CV. The proposal is written jointly with your chosen host organisation(s). The maximum length of a proposal is 10 pages, excluding the CV of the researcher and the annexes.

A Career Development Plan should be established jointly by the host institution supervisor(s) and the researcher. In addition to research or innovation objectives, this plan comprises the researcher's training and career needs, including training on transferable skills, teaching, planning for publications and participation in conferences.

https://ec.europa.eu/research/mariecurieactions/actions/individual-fellowships_en

Interested applicants can identify their own host. Alternatively, European organizations actively seeking applicants under the Individual Fellowship program may be found on the Partner Search List:

https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/interested-org-list/31089249

For assistance, please contact:
Jill Sherman, International Research Facilitator, intl.research@lakeheadu.ca, tel: 807-343-8014

We are pleased to announce the launch of this year’s Canadian Cancer Society Awards for Excellence in cancer research, to recognize individuals who have made, and are making, valuable contributions to cancer research and cancer control in Canada. Recipients are leaders in their fields who exemplify excellence in science and outstanding service to the scientific community.

The nomination deadline is May 29, 2019. Guidelines are available on our website.

Information on previous award winners is available here.